Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

LEPTOSPIRA SP - ANVISA Registration 10259610257

Access comprehensive regulatory information for LEPTOSPIRA SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10259610257 and manufactured by VIRCELL S.L.. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until Jun 09, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including INSTITUT VIRION\SERION GMBH, HANGZHOU ALLTEST BIOTECH CO. LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10259610257
2 Related Devices
Registration Details
ANVISA Registration Number: 10259610257
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

LEPTOSPIRA ELISA IgM
Risk Class III

Registration Details

10259610257

25351361776202420

68814961000173

Company Information

VIRCELL S.L.
Spain
PT: ESPANHA

Dates and Status

Jun 09, 2025

09/06/2035

09/18/2025 19:00:01

LEPTOSPIRA ELISA IgM
Risk Class III

Registration Details

10259610257

25351361776202420

68814961000173

Company Information

Dates and Status

Jun 09, 2025

09/06/2035

09/18/2025 19:00:01